Hyderabad, Telangana, India, March 2025 – Anthea Pharma has announced the appointment of Gaurav Arora as its Vice President – Supply Chain Management, Strategic Sourcing, and Global Procurement. With a distinguished career spanning over 25 years in supply chain, procurement, and risk management, Gaurav will play a pivotal role in driving business transformation, enterprise risk management, and global business continuity for Anthea Pharma’s growing operations. His expertise in strategic sourcing, value chain management, and supply operations will contribute significantly to Anthea Pharma’s mission of becoming a global leader in injectables manufacturing.
Prior to joining Anthea Pharma, Gaurav served as Associate Vice President – Procurement at Medreich Limited, a Meiji-Japan Group company, where he led global sourcing and procurement initiatives, optimizing supplier engagement and driving operational efficiency. Before that, he was General Manager – Procurement (SCM) at Stelis Biopharma, where he played a key role in supply chain management for biologics, CDMO projects, and large-scale vaccine manufacturing.
Gaurav also spent nearly seven years at Biocon, where he held the position of Senior Director – Supply Chain, leading global sourcing, procurement, contract manufacturing, and logistics. He was instrumental in streamlining brownfield projects and ensuring compliance with U.S. FDA standards. His leadership journey includes significant roles at Ajinomoto OmniChem, Torrent Pharmaceuticals, Shriram PolyTech, Nectar Lifesciences, Lupin, and Uncle Chipps, where he gained extensive experience in procurement strategy, supplier engagement, and global risk management.
Gaurav holds an Executive MBA in Retail & Operations Management from The Global Open University and a Diploma in Supply Chain Management from Symbiosis Institute of Management Studies. His strong educational background, coupled with his expertise in global supply chain strategy and procurement transformation, makes him a valuable addition to Anthea Pharma’s leadership team.
About Anthea Pharma
Founded in 2019 and backed by the prestigious Yashoda Group, Anthea Pharma is an R&D-driven injectables company with a vision to manufacture for the world. Headquartered in Hyderabad, India, the company boasts a state-of-the-art R&D facility and an advanced injectable manufacturing plant with a capacity for 20 filling lines, producing a wide range of PFS, cartridges, glass and plastic vials, ampoules, emulsions, lyophilized powders, and aqueous solutions.
With a strong focus on quality, innovation, and global supply chain excellence, Anthea Pharma is committed to delivering high-quality injectable products across therapeutic segments while expanding its global footprint in regulated and emerging markets.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
